Discover
YDES
YD Bio Ltd
6.73
1 x 2.27
1 x 2.38
bid
ask
+
0.94
16.23%
1 @ 06:02 PM
6.74 +0.01 (0.15%)
| Ytd | -44.79% | |
| 1y | -64.03% |
5.61
day range
7.00
1.90
52 week range
20.09
| Open | 5.71 | Prev Close | 5.79 | Low | 5.61 | High | 7.00 | Mkt Cap | 476.69M |
| Vol | 207.79K | Avg Vol | 284.92K | EPS | -0.04 | P/E | N/A | Forward P/E | N/A |
| Beta | 0.16 | Short Ratio | 0.77 | Inst. Own | 0.35% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 4.15 | 200-d Avg | 6.02 | 1yr Est | 0.00 |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|
Profile
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2025-09-29 | Cerity Partners LLC | 32.41K | 429.06K | 0.05% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2025-09-29 | Fidelity Commonwealth Trust-Fidelity Nasdaq Composite Index ETF | 20.86K | 276.21K | 0.03% |